DXCM
DexCom Inc.
Company Overview
| Mkt Cap | $27.15B | Price | $58.22 |
| Volume | 26.56M | Change | -14.63% |
| P/E Ratio | 47.1 | Open | $59.19 |
| Revenue | $4.0B | Prev Close | $68.20 |
| Net Income | $576.2M | 52W Range | $56.45 - $93.25 |
| Div Yield | N/A | Target | $98.96 |
| Overall | 43 | Value | 40 |
| Quality | 55 | Technical | 36 |
No chart data available
Stock Overview
Updated DailyDexCom Inc. (DXCM) is a leading Healthcare company in the Diagnostics & Research industry, currently trading at $58.22 with a market capitalization of $27.15 billion. The stock is approaching its 52-week lows, suggesting potential value opportunity, demonstrating average quality indicators with a MarketXLS quality score of 55.
Today's trading session shows DXCM with a volume of 26.56 million shares. The stock opened down 13.21% from yesterday's close of $68.20. Current analyst estimates project earnings of $2.04 per share for this year, with next year targeting $2.56.
DXCM demonstrates concerning technical signals based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including EW, BDX, WST, TNDM, QDEL.
Key investment considerations for DXCM include below-average investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 70.0%. The stock shows elevated valuation levels based on valuation analysis.
Analysis generated on November 3, 2025 at 09:53 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | DXCM | $58.22 | -14.6% | 26.56M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |